RETHINK
LEARNING
CUSTOM TAILORED MEDICAL EDUCATION
UNDERPINNED BY NEUROSCIENCE
SCROLL DOWN
40
points
Not your usual suspects
This activity focuses on defining neuroendocrine tumour (NET) as a cancer, as well as on the signs, symptoms and classifications of NETs.
Start learning
40
points
Managing Painful Conversations
This activity focuses on the complex needs of patients presenting with chronic non-cancer pain (CNCP).
40
points
Metabolic syndrome
Metabolic syndrome diagnosis and management of associated risk factors.
2
points
Minimally invasive treatment for benign prostatic hyperplasia
This activity describes benign prostatic hyperplasia (BPH), its common symptoms, diagnosis, and reviews management options in patients who are not effectively managed on oral therapies. The emerging role of minimally invasive surgical options for the treatment of BPH is highlighted. Start learning
2
points
Spirometry interpretation: learn from an expert
In this activity, Dr Barton Jennings, MBBS, FRACP, Specialist in Respiratory Medicine and Sleep Disorders, discusses the importance of spirometry testing in general practice and demonstrates how to interpret spirometry results using real patient case studies. Start learning
2
points
Common gastrointestinal complaints
Best practise management of patients with pancreatic exocrine insufficiency (PEI).
2
points
Biosimilar medicines: Information for general practitioners
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling.
Start learning
2
points
Biosimilar medicines in Australia: On-demand webinar for General Practitioners
This on-demand webinar is based on panel discussion with three eminent healthcare professionals.
Start learning
More than skin and bones
This activity will focus on the role of interleukin-17 (IL-17) inhibitors in the treatment of psoriatic arthritis (PsA) patients who showed an inadequate response to conventional disease-modifying antirheumatic drugs (csDMARDs), review the updated treatment guidelines regarding initiation of IL-17 inhibitors, and discuss the clinical evidence to support IL-17 inhibitors.
Start learning
Overview of JAK-inhibitors in Australian clinical practice
Hear from three of Australia’s top rheumatologists – A/Prof Östör, Dr Tellus and A/Prof Bird – in this videocast-style learning activity.
Start learning
Management of rheumatoid arthritis in patients who are inadequately responding to cDMARDS
This activity will focus on the management of existing patients diagnosed with RA who are showing incomplete response to conventional disease-modifying antirheumatic drugs (cDMARD)
Start learning
Management of radioiodine-refractory differentiated thyroid carcinoma (RAI-R DTC)
A case study-based activity focusing on patient selection for, and practical aspects of, tyrosine kinase inhibitors in RAI-R DTC.
Start learning
Biosimilar medicines: Information for specialists
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling.
Start learning
Biosimilar medicines in Australia: On-demand webinar for Specialists
This on-demand webinar is based on panel discussion with three eminent healthcare professionals.
Start learning
Not your usual suspects
This activity focuses on defining neuroendocrine tumour (NET) as a cancer, as well as on the signs, symptoms and classifications of NETs.
Start learning
Spirometry interpretation: learn from an expert
In this activity, Dr Barton Jennings, MBBS, FRACP, Specialist in Respiratory Medicine and Sleep Disorders, discusses the importance of spirometry testing in general practice and demonstrates how to interpret spirometry results using real patient case studies. Start learning
Biosimilar medicines: Information for Nurses
An overview of the development and approval processes of biosimilar medicines in Australia. Start learning
PEI Online Education Module for Dietitians
This module covers the pathophysiology of PEI, risk factors, signs and symptoms, complications, diagnosis,
management strategies, such as treatment with pancreatic enzyme replacement therapy (PERT), including CREON®.
Start learning
1
point
Biosimilar medicines: Information for pharmacists
An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on dispensing and counselling.
Start learning
1
point
Biosimilar medicines in Australia: On-demand webinar for Pharmacists
This on-demand webinar is based on panel discussion with eminent healthcare professionals.
Start learning
Asthma
Mental health
Medicinal cannabis
Neuroscience
Anticoagulants
Men’s health
Your patients,
your government
MULTIDISCIPLINARY FORUM AND WORKSHOP,
PARLIAMENT HOUSE, SYDNEY.
CLOSED EVENT
Panellists
NOACs
Opthalmology Audit
Anaphylaxis
Simplifying treatment in type 2 diabetes(T2D)
GP Psychiatry Support
Bioinformatics
Chronic Obstructive Pulmonary Disease
Dermatology
Erectile Dysfunction
Heart Failure
Neurology
Osteoporosis
of HCPs say our programs
exceeded expectations
Polling and insight gathering allows the
client to track customer trends, reducing
$000s in market research cost
We glean granular insights from
HCPs and we know what they
want to learn
We create inspiring multi-channel medical
education programs
in both accredited and non-accredited formats for a variety of audiences including specialists, GPs, pharmacists, pharmacy assistants, nurses and patients.
|
Medical and scientific writingOur in-house writing team includes three PhDs and boasts wide-ranging experience and expertise in multiple therapeutic areas. |
|
Digital education programsOur online educational programs include live webinars, CME-accredited web-based learning and nationwide coverage of live events streamed to home computers. |
|
Medical and scientific writingOur in-house writing team includes three PhDs and boasts wide-ranging experience and expertise in multiple therapeutic areas. |
|
Patient programsOur services include research into what is required for any patient program, conceptual development, material development, digital requirements, logistics, 3rd party support (if required) and reporting. |
|
Promotional meeting supportOur wide-ranging experience covers every aspect of the production of promotional meetings including content planning, template design, KOL and meeting management, and platform development and implementation (digital or live). |
|
Conference planningOur on-staff team of trainers and support personnel work hand-in-hand with your in-house resources to deliver a seamless conference planning function designed to maximise stakeholder engagement around pre-agreed outcomes. |
|
CME/CPD programs/meetingsWe are category 1 and 2 QI&CPD providers for the RACGP and have developed numerous programs accredited by the RACGP, ACRRM and PSA. |
|
Slide kitsDevelopment of slides for speakers – either individual presentations or kits used in meeting series across the country. We can work with steering committees to develop content or provide editing and animation services for individuals as meeting support for our presenters. |
|
Advisory boards and masterclassesWe can help with commissioning, running, logistics, agenda preparation, pre-reading, content preparation and reporting for advisory board meetings and masterclasses. |
|
|
KOL managementWe work closely with many Key Opinion Leaders in different therapeutic areas, both in Australia and overseas. Our services include speaker briefing and liaison along with development and management of steering committees and advisory boards. We also work with many NGOs, colleges and government departments. |
|
Scientific symposiaWe offer steering committee support, agenda development, presentation materials, polling and webcast options along with highlights, meeting evaluation forms and material follow up. |
|
Educational AidsWe can develop both digital and print educational material to increase disease awareness amongst healthcare professionals, such as education about diagnosis and management, and to assist patients in understanding how to manage their disease. |
Need an agency to drive your
med ed programs?
